Global Patient Risk Capital Investment Market 2020 by Company, Regions, Type and Application, Forecast to 2025

Table of Contents

1 Patient Risk Capital Investment Market Overview

• 1.1 Product Overview and Scope of Patient Risk Capital Investment
• 1.2 Classification of Patient Risk Capital Investment by Type
  • 1.2.1 Global Patient Risk Capital Investment Revenue by Type: 2015 VS 2019 VS 2025
  • 1.2.2 Global Patient Risk Capital Investment Revenue Market Share by Type in 2019
  • 1.2.3 Early Stage Financing
  • 1.2.4 Expansion Financing
  • 1.2.5 Acquisition or Buyout Financing
• 1.3 Global Patient Risk Capital Investment Market by Application
  • 1.3.1 Overview: Global Patient Risk Capital Investment Revenue by Application: 2015 VS 2019 VS 2025
  • 1.3.2 High Technology Industries
  • 1.3.3 Innovative Technology Company
• 1.4 Global Patient Risk Capital Investment Market by Regions
  • 1.4.1 Global Patient Risk Capital Investment Market Size by Regions: 2015 VS 2019 VS 2025
  • 1.4.2 Global Market Size of Patient Risk Capital Investment (2015-2025)
  • 1.4.3 North America (USA, Canada and Mexico) Patient Risk Capital Investment Status and Prospect (2015-2025)
  • 1.4.4 Europe (Germany, France, UK, Russia and Italy) Patient Risk Capital Investment Status and Prospect (2015-2025)
  • 1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Patient Risk Capital Investment Status and Prospect (2015-2025)
  • 1.4.6 South America (Brazil, Argentina, Colombia) Patient Risk Capital Investment Status and Prospect (2015-2025)
  • 1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Patient Risk Capital Investment Status and Prospect (2015-2025)

2 Company Profiles

• 2.1 Accel
  • 2.1.1 Accel Details
  • 2.1.2 Accel Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.1.3 Accel SWOT Analysis
  • 2.1.4 Accel Product and Services
  • 2.1.5 Accel Patient Risk Capital Investment Revenue, Gross Margin and Market Share (2018-2019)
• 2.2 Bessemer Venture Partners
  • 2.2.1 Bessemer Venture Partners Details
  • 2.2.2 Bessemer Venture Partners Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.2.3 Bessemer Venture Partners SWOT Analysis
  • 2.2.4 Bessemer Venture Partners Product and Services
  • 2.2.5 Bessemer Venture Partners Patient Risk Capital Investment Revenue, Gross Margin and Market Share (2018-2019)
• 2.3 Lowercase Capital
  • 2.3.1 Lowercase Capital Details
  • 2.3.2 Lowercase Capital Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.3.3 Lowercase Capital SWOT Analysis
  • 2.3.4 Lowercase Capital Product and Services
  • 2.3.5 Lowercase Capital Patient Risk Capital Investment Revenue, Gross Margin and Market Share (2018-2019)
• 2.4 Benchmark Capital
  • 2.4.1 Benchmark Capital Details
  • 2.4.2 Benchmark Capital Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.4.3 Benchmark Capital SWOT Analysis
  • 2.4.4 Benchmark Capital Product and Services
  • 2.4.5 Benchmark Capital Patient Risk Capital Investment Revenue, Gross Margin and Market Share (2018-2019)
• 2.5 Andreessen Horowitz
  • 2.5.1 Andreessen Horowitz Details
  • 2.5.2 Andreessen Horowitz Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.5.3 Andreessen Horowitz SWOT Analysis
  • 2.5.4 Andreessen Horowitz Product and Services
  • 2.5.5 Andreessen Horowitz Patient Risk Capital Investment Revenue, Gross Margin and Market Share (2018-2019)
• 2.6 First Round Capital
  • 2.6.1 First Round Capital Details
  • 2.6.2 First Round Capital Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.6.3 First Round Capital SWOT Analysis
  • 2.6.4 First Round Capital Product and Services
  • 2.6.5 First Round Capital Patient Risk Capital Investment Revenue, Gross Margin and Market Share (2018-2019)
• 2.7 Kleiner Perkins Caufield & Byers
  • 2.7.1 Kleiner Perkins Caufield & Byers Details
  • 2.7.2 Kleiner Perkins Caufield & Byers Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.7.3 Kleiner Perkins Caufield & Byers SWOT Analysis
  • 2.7.4 Kleiner Perkins Caufield & Byers Product and Services
  • 2.7.5 Kleiner Perkins Caufield & Byers Patient Risk Capital Investment Revenue, Gross Margin and Market Share (2018-2019)
• 2.8 UNION SQUARE VENTURES
  • 2.8.1 UNION SQUARE VENTURES Details
  • 2.8.2 UNION SQUARE VENTURES Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.8.3 UNION SQUARE VENTURES SWOT Analysis
  • 2.8.4 UNION SQUARE VENTURES Product and Services
  • 2.8.5 UNION SQUARE VENTURES Patient Risk Capital Investment Revenue, Gross Margin and Market Share (2018-2019)
• 2.9 Sequoia Capital
  • 2.9.1 Sequoia Capital Details
  • 2.9.2 Sequoia Capital Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.9.3 Sequoia Capital SWOT Analysis
  • 2.9.4 Sequoia Capital Product and Services
  • 2.9.5 Sequoia Capital Patient Risk Capital Investment Revenue, Gross Margin and Market Share (2018-2019)
• 2.10 Greylock Partners
  • 2.10.1 Greylock Partners Details
  • 2.10.2 Greylock Partners Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.10.3 Greylock Partners SWOT Analysis
  • 2.10.4 Greylock Partners Product and Services
  • 2.10.5 Greylock Partners Patient Risk Capital Investment Revenue, Gross Margin and Market Share (2018-2019)
• 2.11 New Enterprise Associates
  • 2.11.1 New Enterprise Associates Details
  • 2.11.2 New Enterprise Associates Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.11.3 New Enterprise Associates SWOT Analysis
  • 2.11.4 New Enterprise Associates Product and Services
  • 2.11.5 New Enterprise Associates Patient Risk Capital Investment Revenue, Gross Margin and Market Share (2018-2019)
• 2.12 Baseline Ventures
  • 2.12.1 Baseline Ventures Details
  • 2.12.2 Baseline Ventures Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.12.3 Baseline Ventures SWOT Analysis
  • 2.12.4 Baseline Ventures Product and Services
  • 2.12.5 Baseline Ventures Patient Risk Capital Investment Revenue, Gross Margin and Market Share (2018-2019)
• 2.13 Index Ventures
  • 2.13.1 Index Ventures Details
  • 2.13.2 Index Ventures Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.13.3 Index Ventures SWOT Analysis
  • 2.13.4 Index Ventures Product and Services
  • 2.13.5 Index Ventures Patient Risk Capital Investment Revenue, Gross Margin and Market Share (2018-2019)
• 2.14 Breyer Capital
  • 2.14.1 Breyer Capital Details
  • 2.14.2 Breyer Capital Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.14.3 Breyer Capital SWOT Analysis
  • 2.14.4 Breyer Capital Product and Services
  • 2.14.5 Breyer Capital Patient Risk Capital Investment Revenue, Gross Margin and Market Share (2018-2019)
• 2.15 Founders Fund
  • 2.15.1 Founders Fund Details
  • 2.15.2 Founders Fund Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.15.3 Founders Fund SWOT Analysis
  • 2.15.4 Founders Fund Product and Services
  • 2.15.5 Founders Fund Patient Risk Capital Investment Revenue, Gross Margin and Market Share (2018-2019)

3 Market Competition, by Players

• 3.1 Global Patient Risk Capital Investment Revenue and Share by Players (2015-2020)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Patient Risk Capital Investment Players Market Share
  • 3.2.2 Top 10 Patient Risk Capital Investment Players Market Share
• 3.3 Market Competition Trend

4 Market Size by Regions

• 4.1 Global Patient Risk Capital Investment Revenue and Market Share by Regions
• 4.2 North America Patient Risk Capital Investment Revenue and Growth Rate (2015-2020)
• 4.3 Europe Patient Risk Capital Investment Revenue and Growth Rate (2015-2020)
• 4.4 Asia-Pacific Patient Risk Capital Investment Revenue and Growth Rate (2015-2020)
• 4.5 South America Patient Risk Capital Investment Revenue and Growth Rate (2015-2020)
• 4.6 Middle East & Africa Patient Risk Capital Investment Revenue and Growth Rate (2015-2020)

5 North America Patient Risk Capital Investment Revenue by Countries

• 5.1 North America Patient Risk Capital Investment Revenue by Countries (2015-2020)
• 5.2 USA Patient Risk Capital Investment Revenue and Growth Rate (2015-2020)
• 5.3 Canada Patient Risk Capital Investment Revenue and Growth Rate (2015-2020)
• 5.4 Mexico Patient Risk Capital Investment Revenue and Growth Rate (2015-2020)

6 Europe Patient Risk Capital Investment Revenue by Countries

• 6.1 Europe Patient Risk Capital Investment Revenue by Countries (2015-2020)
• 6.2 Germany Patient Risk Capital Investment Revenue and Growth Rate (2015-2020)
• 6.3 UK Patient Risk Capital Investment Revenue and Growth Rate (2015-2020)
• 6.4 France Patient Risk Capital Investment Revenue and Growth Rate (2015-2020)
• 6.5 Russia Patient Risk Capital Investment Revenue and Growth Rate (2015-2020)
• 6.6 Italy Patient Risk Capital Investment Revenue and Growth Rate (2015-2020)

7 Asia-Pacific Patient Risk Capital Investment Revenue by Countries

• 7.1 Asia-Pacific Patient Risk Capital Investment Revenue by Countries (2015-2020)
• 7.2 China Patient Risk Capital Investment Revenue and Growth Rate (2015-2020)
• 7.3 Japan Patient Risk Capital Investment Revenue and Growth Rate (2015-2020)
• 7.4 Korea Patient Risk Capital Investment Revenue and Growth Rate (2015-2020)
• 7.5 India Patient Risk Capital Investment Revenue and Growth Rate (2015-2020)
• 7.6 Southeast Asia Patient Risk Capital Investment Revenue and Growth Rate (2015-2020)

8 South America Patient Risk Capital Investment Revenue by Countries

• 8.1 South America Patient Risk Capital Investment Revenue by Countries (2015-2020)
• 8.2 Brazil Patient Risk Capital Investment Revenue and Growth Rate (2015-2020)
• 8.3 Argentina Patient Risk Capital Investment Revenue and Growth Rate (2015-2020)

9 Middle East & Africa Revenue Patient Risk Capital Investment by Countries

• 9.1 Middle East & Africa Patient Risk Capital Investment Revenue by Countries (2015-2020)
• 9.2 Saudi Arabia Patient Risk Capital Investment Revenue and Growth Rate (2015-2020)
• 9.3 UAE Patient Risk Capital Investment Revenue and Growth Rate (2015-2020)
• 9.4 Egypt Patient Risk Capital Investment Revenue and Growth Rate (2015-2020)
• 9.5 South Africa Patient Risk Capital Investment Revenue and Growth Rate (2015-2020)

10 Market Size Segment by Type

• 10.1 Global Patient Risk Capital Investment Revenue and Market Share by Type (2015-2020)
• 10.2 Global Patient Risk Capital Investment Market Forecast by Type (2019-2024)
• 10.3 Early Stage Financing Revenue Growth Rate (2015-2025)
• 10.4 Expansion Financing Revenue Growth Rate (2015-2025)
• 10.5 Acquisition or Buyout Financing Revenue Growth Rate (2015-2025)

11 Global Patient Risk Capital Investment Market Segment by Application

• 11.1 Global Patient Risk Capital Investment Revenue Market Share by Application (2015-2020)
• 11.2 Patient Risk Capital Investment Market Forecast by Application (2019-2024)
• 11.3 High Technology Industries Revenue Growth (2015-2020)
• 11.4 Innovative Technology Company Revenue Growth (2015-2020)

12 Global Patient Risk Capital Investment Market Size Forecast (2021-2025)

• 12.1 Global Patient Risk Capital Investment Market Size Forecast (2021-2025)
• 12.2 Global Patient Risk Capital Investment Market Forecast by Regions (2021-2025)
• 12.3 North America Patient Risk Capital Investment Revenue Market Forecast (2021-2025)
• 12.4 Europe Patient Risk Capital Investment Revenue Market Forecast (2021-2025)
• 12.5 Asia-Pacific Patient Risk Capital Investment Revenue Market Forecast (2021-2025)
• 12.6 South America Patient Risk Capital Investment Revenue Market Forecast (2021-2025)
• 12.7 Middle East & Africa Patient Risk Capital Investment Revenue Market Forecast (2021-2025)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology
• 14.2 Data Source
• 14.3 Disclaimer